Malignant Struma ovarii in a 30-year old nulliparous patient
ConclusionsWe believe that aggressive surgical management followed by radioiodine therapy is best to reduce recurrence risk and optimize survival. The broad scope of interventions needed to treat malignant struma ovarii require a strong interdisciplinary team.
Source: Thyroid Research - Category: Endocrinology Source Type: research
More News: Cancer & Oncology | Carcinoma | Endocrinology | Germ Cell Tumors | Laparoscopy | Ovarian Cancer | Ovaries | Pain | Pain Management | Radioiodine Therapy | Thyroid | Thyroid Cancer | Thyroidectomy | Ultrasound